Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Feb 01, 2021 4:51pm
173 Views
Post# 32439953

RE:RE:RE:RE:RE:RE:RE:RE:MedX Announces Closings of First $2.5 Million of Convertible

RE:RE:RE:RE:RE:RE:RE:RE:MedX Announces Closings of First $2.5 Million of ConvertibleI think it will happen in stages, firstly you will see as a shareholder the number of locations open. You will be able to track that on their site. MedX has already announced they have an AI strategy which I hope they will give a progress report on shortly. Then we should be able to determine what the monetization component of their data and AI is worth by number of datapoints they capture from each location. Converting that data to money is the model that we don't know yet once we understand that and once they have a large volume of scans daily then we should be off to the races.

My best guess on the timeline is Q3-4. The reason I think this is of such value is MedX's image capture technology is the best in the world. It takes a perfect image on the surface of the skin as well as below the surface of the skin everytime and that is a major differentiator to any other AI system in the market using conventional image capture devices (phones). Remember 40% of images captured by iphones and sent to Dermatologists are unassessable. MedX does not have this issue. So MedX may have a huge advantage in the Datamining/AI world and that is worth a fortune to the pharmacology companies as well as a yield management tool to the dermatological community.

Thank you for your comments 
<< Previous
Bullboard Posts
Next >>